Early Life Blockade of 5-Hydroxytryptamine 1A Receptors Normalizes Sleep and Depression-Like Behavior in Adult Knock-Out Mice Lacking the Serotonin Transporter
Open Access
- 17 May 2006
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 26 (20) , 5554-5564
- https://doi.org/10.1523/jneurosci.5156-05.2006
Abstract
In serotonin transporter knock-out (5-HTT−/−) mice, extracellular serotonin (5-HT) levels are markedly elevated in the brain, and rapid eye movement sleep (REMS) is enhanced compared with wild-type mice. We hypothesized that such sleep impairment at adulthood results from excessive serotonergic tone during early life. Thus, we assessed whether neonatal treatment with drugs capable of limiting the impact of 5-HT on the brain could normalize sleep patterns in 5-HTT−/− mutants. We found that treatments initiated at postnatal day 5 and continued for 2 weeks with the 5-HT synthesis inhibitorpara-chlorophenylalanine, or for 4 weeks with the 5-HT1Areceptor (5-HT1AR) antagonistN-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635), induced total or partial recovery of REMS, respectively, in 5-HTT−/− mutants. Early life treatment with WAY 100635 also reversed the depression-like behavior otherwise observed in these mutants. Possible adaptive changes in 5-HT1AR after neonatal treatment with WAY 100635 were investigated by measuring 5-HT1Abinding sites and 5-HT1AmRNA in various REMS- and/or depression-related brain areas, as well as 5-HT1AR-mediated hypothermia and inhibition of neuronal firing in the dorsal raphe nucleus. None of these characteristics were modified in parallel with REMS recovery, suggesting that 5-HT1ARs involved in wild-type phenotype rescue in 5-HTT−/− mutants are located in other brain areas or in 5-HT1AR-unrelated circuits where they could be transiently expressed during development. The reversal of sleep alterations and depression-like behavior after early life blockade of 5-HT1AR in 5-HTT−/− mutants might open new perspectives regarding preventive care of sleep and mood disorders resulting from serotonin transporter impairments during development.Keywords
This publication has 55 references indexed in Scilit:
- Homeostatic Regulation of Sleep in a Genetic Model of Depression in the Mouse: Effects of Muscarinic and 5-HT1A Receptor ActivationNeuropsychopharmacology, 2005
- Ontogeny of 5-HT1A receptor expression in the developing hippocampusDevelopmental Brain Research, 2005
- Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during developmentDevelopmental Brain Research, 2004
- Involvement of 5-HT 1A Receptors in Animal Tests of Anxiety and Depression: Evidence from Genetic ModelsStress, 2003
- Altered rapid eye movement sleep timing in serotonin transporter knockout miceNeuroReport, 2003
- 5-HT1A/1B Receptor-Mediated Effects of the Selective Serotonin Reuptake Inhibitor, Citalopram, on Sleep: Studies in 5-HT1A and 5-HT1B Knockout MiceNeuropsychopharmacology, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- The critical window of brain development from susceptive to insusceptive: Effects of clomipramine neonatal treatment on sexual behaviorDevelopmental Brain Research, 2001
- Effects of neonatal serotonin depletion on the development of rat dentate granule cellsDevelopmental Brain Research, 1997
- A new animal model of endogenous depression: A summary of present findingsNeuroscience & Biobehavioral Reviews, 1990